(PUB) Publicis e - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000130577
Stock: Marketing, Communications, Media, Digital, Health
Total Rating 35
Risk 79
Buy Signal -0.36
| Risk 5d forecast | |
|---|---|
| Volatility | 24.6% |
| Relative Tail Risk | -4.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.54 |
| Alpha | -25.03 |
| Character TTM | |
|---|---|
| Beta | 0.432 |
| Beta Downside | 0.392 |
| Drawdowns 3y | |
|---|---|
| Max DD | 31.78% |
| CAGR/Max DD | 0.19 |
Description: PUB Publicis e February 25, 2026
Publicis Groupe S.A. (ticker PUB) is a global leader in marketing, communications, and digital transformation, operating across North America, Europe, Asia-Pacific, Latin America, Africa, and the Middle East. Its portfolio includes Publicis Communications, Publicis Sapient, Publicis Media, Publicis Health, and specialized healthcare communication services, all built around the “Power of One” integrated model.
In FY 2025 the group generated €13.2 billion in revenue, a 5.4 % year-over-year increase driven by strong growth in digital services (+9 % YoY) and a 12 % rise in programmatic media spend. Operating margin expanded to 12.8 % as cost-efficiency initiatives took hold, while the return on equity reached 15.2 %. The advertising sector is being propelled by the continued shift to data-driven, AI-enabled campaigns and the projected global programmatic ad spend surpassing $200 billion in 2025.
For a deeper dive into Publicis’s valuation and outlook, you might explore the latest analysis on ValueRay.
Headlines to watch out for
- Global advertising spending impacts agency revenue
- Digital transformation services drive new client acquisition
- Economic downturns reduce marketing budgets
- Data privacy regulations increase operational costs
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.74b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 3.91 > 1.0 |
| NWC/Revenue: -2.94% < 20% (prev -8.88%; Δ 5.94% < -1%) |
| CFO/TA 0.13 > 3% & CFO 5.33b > Net Income 2.74b |
| Net Debt (3.45b) to EBITDA (5.21b): 0.66 < 3 |
| Current Ratio: 0.97 > 1.5 & < 3 |
| Outstanding Shares: last quarter (253.4m) vs 12m ago 0.04% < -2% |
| Gross Margin: 21.54% > 18% (prev 0.26%; Δ 2128 % > 0.5%) |
| Asset Turnover: 73.86% > 50% (prev 72.40%; Δ 1.46% > 0%) |
| Interest Coverage Ratio: 15.87 > 6 (EBITDA TTM 5.21b / Interest Expense TTM 254.5m) |
Altman Z'' 1.49
| A: -0.02 (Total Current Assets 23.07b - Total Current Liabilities 23.89b) / Total Assets 40.01b |
| B: 0.20 (Retained Earnings 8.08b / Total Assets 40.01b) |
| C: 0.11 (EBIT TTM 4.04b / Avg Total Assets 37.96b) |
| D: 0.24 (Book Value of Equity 7.16b / Total Liabilities 29.59b) |
| Altman-Z'' Score: 1.49 = BB |
Beneish M -2.78
| DSRI: 1.11 (Receivables 17.72b/14.74b, Revenue 28.04b/26.00b) |
| GMI: 1.23 (GM 21.54% / 26.41%) |
| AQI: 0.93 (AQ_t 0.37 / AQ_t-1 0.40) |
| SGI: 1.08 (Revenue 28.04b / 26.00b) |
| TATA: -0.06 (NI 2.74b - CFO 5.33b) / TA 40.01b) |
| Beneish M-Score: -2.78 (Cap -4..+1) = A |
What is the price of PUB shares?
As of March 10, 2026, the stock is trading at EUR 75.88 with a total of 796,462 shares traded.
Over the past week, the price has changed by +2.04%, over one month by -5.41%, over three months by -13.22% and over the past year by -16.74%.
Over the past week, the price has changed by +2.04%, over one month by -5.41%, over three months by -13.22% and over the past year by -16.74%.
Is PUB a buy, sell or hold?
Publicis e has no consensus analysts rating.
What are the forecasts/targets for the PUB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 113.3 | 49.4% |
| Analysts Target Price | - | - |
PUB Fundamental Data Overview March 05, 2026
Market Cap USD = 25.26b (21.94b EUR * 1.1513 EUR.USD)
P/E Trailing = 12.96
P/E Forward = 8.8339
P/S = 1.0586
P/B = 1.7631
P/EG = 2.0396
Revenue TTM = 28.04b EUR
EBIT TTM = 4.04b EUR
EBITDA TTM = 5.21b EUR
Long Term Debt = 3.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 760.0m EUR (from shortTermDebt, last quarter)
Debt = 7.48b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.45b EUR (from netDebt column, last quarter)
Enterprise Value = 25.22b EUR (21.94b + Debt 7.48b - CCE 4.20b)
Interest Coverage Ratio = 15.87 (Ebit TTM 4.04b / Interest Expense TTM 254.5m)
EV/FCF = 5.21x (Enterprise Value 25.22b / FCF TTM 4.84b)
FCF Yield = 19.18% (FCF TTM 4.84b / Enterprise Value 25.22b)
FCF Margin = 17.25% (FCF TTM 4.84b / Revenue TTM 28.04b)
Net Margin = 9.78% (Net Income TTM 2.74b / Revenue TTM 28.04b)
Gross Margin = 21.54% ((Revenue TTM 28.04b - Cost of Revenue TTM 22.00b) / Revenue TTM)
Gross Margin QoQ = 13.87% (prev 14.13%)
Tobins Q-Ratio = 0.63 (Enterprise Value 25.22b / Total Assets 40.01b)
Interest Expense / Debt = 0.17% (Interest Expense 13.0m / Debt 7.48b)
Taxrate = 27.28% (311.0m / 1.14b)
NOPAT = 2.94b (EBIT 4.04b * (1 - 27.28%))
Current Ratio = 0.97 (Total Current Assets 23.07b / Total Current Liabilities 23.89b)
Debt / Equity = 0.72 (Debt 7.48b / totalStockholderEquity, last quarter 10.45b)
Debt / EBITDA = 0.66 (Net Debt 3.45b / EBITDA 5.21b)
Debt / FCF = 0.71 (Net Debt 3.45b / FCF TTM 4.84b)
Total Stockholder Equity = 10.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.22% (Net Income 2.74b / Total Assets 40.01b)
RoE = 26.71% (Net Income TTM 2.74b / Total Stockholder Equity 10.26b)
RoCE = 30.26% (EBIT 4.04b / Capital Employed (Equity 10.26b + L.T.Debt 3.08b))
RoIC = 21.74% (NOPAT 2.94b / Invested Capital 13.51b)
WACC = 5.63% (E(21.94b)/V(29.42b) * Re(7.51%) + D(7.48b)/V(29.42b) * Rd(0.17%) * (1-Tc(0.27)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.18%
[DCF] Terminal Value 88.43% ; FCFF base≈4.08b ; Y1≈5.03b ; Y5≈8.57b
[DCF] Fair Price = 981.0 (EV 249.49b - Net Debt 3.45b = Equity 246.04b / Shares 250.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 24.89 | EPS CAGR: 129.4% | SUE: -1.01 | # QB: 0
Revenue Correlation: 41.67 | Revenue CAGR: 39.99% | SUE: 0.94 | # QB: 2
EPS next Year (2026-12-31): EPS=7.95 | Chg7d=+0.000 | Chg30d=+0.034 | Revisions Net=+3 | Growth EPS=+5.5% | Growth Revenue=+4.2%
P/E Trailing = 12.96
P/E Forward = 8.8339
P/S = 1.0586
P/B = 1.7631
P/EG = 2.0396
Revenue TTM = 28.04b EUR
EBIT TTM = 4.04b EUR
EBITDA TTM = 5.21b EUR
Long Term Debt = 3.08b EUR (from longTermDebt, last quarter)
Short Term Debt = 760.0m EUR (from shortTermDebt, last quarter)
Debt = 7.48b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.45b EUR (from netDebt column, last quarter)
Enterprise Value = 25.22b EUR (21.94b + Debt 7.48b - CCE 4.20b)
Interest Coverage Ratio = 15.87 (Ebit TTM 4.04b / Interest Expense TTM 254.5m)
EV/FCF = 5.21x (Enterprise Value 25.22b / FCF TTM 4.84b)
FCF Yield = 19.18% (FCF TTM 4.84b / Enterprise Value 25.22b)
FCF Margin = 17.25% (FCF TTM 4.84b / Revenue TTM 28.04b)
Net Margin = 9.78% (Net Income TTM 2.74b / Revenue TTM 28.04b)
Gross Margin = 21.54% ((Revenue TTM 28.04b - Cost of Revenue TTM 22.00b) / Revenue TTM)
Gross Margin QoQ = 13.87% (prev 14.13%)
Tobins Q-Ratio = 0.63 (Enterprise Value 25.22b / Total Assets 40.01b)
Interest Expense / Debt = 0.17% (Interest Expense 13.0m / Debt 7.48b)
Taxrate = 27.28% (311.0m / 1.14b)
NOPAT = 2.94b (EBIT 4.04b * (1 - 27.28%))
Current Ratio = 0.97 (Total Current Assets 23.07b / Total Current Liabilities 23.89b)
Debt / Equity = 0.72 (Debt 7.48b / totalStockholderEquity, last quarter 10.45b)
Debt / EBITDA = 0.66 (Net Debt 3.45b / EBITDA 5.21b)
Debt / FCF = 0.71 (Net Debt 3.45b / FCF TTM 4.84b)
Total Stockholder Equity = 10.26b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.22% (Net Income 2.74b / Total Assets 40.01b)
RoE = 26.71% (Net Income TTM 2.74b / Total Stockholder Equity 10.26b)
RoCE = 30.26% (EBIT 4.04b / Capital Employed (Equity 10.26b + L.T.Debt 3.08b))
RoIC = 21.74% (NOPAT 2.94b / Invested Capital 13.51b)
WACC = 5.63% (E(21.94b)/V(29.42b) * Re(7.51%) + D(7.48b)/V(29.42b) * Rd(0.17%) * (1-Tc(0.27)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.18%
[DCF] Terminal Value 88.43% ; FCFF base≈4.08b ; Y1≈5.03b ; Y5≈8.57b
[DCF] Fair Price = 981.0 (EV 249.49b - Net Debt 3.45b = Equity 246.04b / Shares 250.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 24.89 | EPS CAGR: 129.4% | SUE: -1.01 | # QB: 0
Revenue Correlation: 41.67 | Revenue CAGR: 39.99% | SUE: 0.94 | # QB: 2
EPS next Year (2026-12-31): EPS=7.95 | Chg7d=+0.000 | Chg30d=+0.034 | Revisions Net=+3 | Growth EPS=+5.5% | Growth Revenue=+4.2%